DU, Yu et al. Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study . Dermatology Practical & Conceptual, [S. l.], v. 14, n. 1, p. e2024026, 2024. DOI: 10.5826/dpc.1401a26. Disponível em: https://dpcj.org/index.php/dpc/article/view/3517.. Acesso em: 19 apr. 2026.